This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2003 May;17(5):978-9.

doi: 10.1038/sj.leu.2402910.

Histological features of acute hepatitis after imatinib mesylate treatment

C James, H Trouette, G Marit, P Cony-Makhoul, F-X Mahon

PMID: 12750713
DOI: 10.1038/sj.leu.2402910

Case Reports

Histological features of acute hepatitis after imatinib mesylate treatment

C James et al. Leukemia. 2003 May.

. 2003 May;17(5):978-9.

doi: 10.1038/sj.leu.2402910.

Authors

C James, H Trouette, G Marit, P Cony-Makhoul, F-X Mahon

PMID: 12750713
DOI: 10.1038/sj.leu.2402910

No abstract available

PubMed Disclaimer

Comment on

Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis.
Ohyashiki K, Kuriyama Y, Nakajima A, Tauchi T, Ito Y, Miyazawa H, Kimura Y, Serizawa H, Ebihara Y. Ohyashiki K, et al. Leukemia. 2002 Oct;16(10):2160-1. doi: 10.1038/sj.leu.2402702. Leukemia. 2002. PMID: 12357373 No abstract available.

Similar articles

[Imatinib mesylate-induced acute cytolytic hepatitis].
Rocca P, El Jastimi S, Troncy J, Scoazec JY, Boucher A, Vial T, Trépo C, Zoulim F. Rocca P, et al. Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):918-9. doi: 10.1016/s0399-8320(04)95160-3. Gastroenterol Clin Biol. 2004. PMID: 15523233 French. No abstract available.
Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis.
Ohyashiki K, Kuriyama Y, Nakajima A, Tauchi T, Ito Y, Miyazawa H, Kimura Y, Serizawa H, Ebihara Y. Ohyashiki K, et al. Leukemia. 2002 Oct;16(10):2160-1. doi: 10.1038/sj.leu.2402702. Leukemia. 2002. PMID: 12357373 No abstract available.
Nilotinib in a patient with postnecrotic liver cirrhosis related to imatinib.
Spataro V. Spataro V. J Clin Oncol. 2011 Jan 20;29(3):e50-2. doi: 10.1200/JCO.2010.30.5359. Epub 2010 Oct 18. J Clin Oncol. 2011. PMID: 20956624 No abstract available.
[Imatinib-induced toxic hepatitis: description of two cases and review of the literature].
Fuster F, Medina L, Vallansot R, Granell M, Bruguera M. Fuster F, et al. Gastroenterol Hepatol. 2007 Nov;30(9):525-30. doi: 10.1157/13111687. Gastroenterol Hepatol. 2007. PMID: 17980129 Review. Spanish.
Imatinib mesylate-induced acute hepatitis in a patient treated for gastrointestinal stromal tumour.
Pariente A, Etcharry F, Cales V, Laborde Y, Ferrari S, Biour M. Pariente A, et al. Eur J Gastroenterol Hepatol. 2006 Jul;18(7):785-7. doi: 10.1097/01.meg.0000216941.42306.0e. Eur J Gastroenterol Hepatol. 2006. PMID: 16772838 Review.

See all similar articles

Cited by

Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives.
Shah RR, Morganroth J, Shah DR. Shah RR, et al. Drug Saf. 2013 Jul;36(7):491-503. doi: 10.1007/s40264-013-0048-4. Drug Saf. 2013. PMID: 23620168 Review.
Successful imatinib treatment of cardiac involvement of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia followed by severe hepatotoxicity.
Arai A, Yan W, Wakabayashi S, Hayashi S, Inazawa J, Miura O. Arai A, et al. Int J Hematol. 2007 Oct;86(3):233-7. doi: 10.1532/IJH97.07032. Int J Hematol. 2007. PMID: 17988989 Review.
Imatinib mesylate (gleevec) hepatotoxicity.
Mindikoglu AL, Regev A, Bejarano PA, Martinez EJ, Jeffers LJ, Schiff ER. Mindikoglu AL, et al. Dig Dis Sci. 2007 Feb;52(2):598-601. doi: 10.1007/s10620-006-9117-1. Epub 2007 Jan 12. Dig Dis Sci. 2007. PMID: 17219077 No abstract available.
Novel Score-based Decision Approach in Chronic Myeloid Leukemia Patients After Acute Toxic Imatinib-induced Liver Injury.
Lopina N, Dmytrenko I, Hamov D, Lopin D, Dyagil I. Lopina N, et al. Cureus. 2019 Apr 9;11(4):e4411. doi: 10.7759/cureus.4411. Cureus. 2019. PMID: 31245199 Free PMC article. Review.
Severe hepatic injury caused by imatinib mesylate administered for the treatment of chronic myeloid leukemia and the efficacy of prednisolone for its management.
Ikuta K, Torimoto Y, Jimbo J, Inamura J, Shindo M, Sato K, Tokusashi Y, Miyokawa N, Kohgo Y. Ikuta K, et al. Int J Hematol. 2005 Nov;82(4):343-6. doi: 10.1532/IJH97.05034. Int J Hematol. 2005. PMID: 16298828

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information

NODES